US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist

16.570
+0.700+4.41%

Close May 28 16:00 ET

1.96BMarket Cap29.59P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

164.50%31.93M

23.74%143.6M

38.85%55.65M

9.27%45.13M

17.42%30.75M

42.37%12.07M

92.22%116.05M

109.00%40.08M

90.27%41.3M

67.09%26.19M

Net income from continuing operations

-21.28%23.28M

-14.05%71.41M

36.80%34.84M

-235.24%-30.76M

74.67%37.76M

123.31%29.57M

110.42%83.08M

173.62%25.47M

120.23%22.75M

77.48%21.62M

Operating gains losses

6.25%68K

-74.03%262K

6.35%67K

-65.45%66K

--65K

--64K

245.55%1.01M

-17.11%63K

76.85%191K

----

Depreciation and amortization

42.88%9.43M

2,553.83%32.88M

1,386.67%9.14M

1,449.37%8.57M

23,062.16%8.57M

19,311.76%6.6M

545.31%1.24M

1,763.64%615K

1,683.87%553K

19.35%37K

Deferred tax

-14.94%-1.75M

-460.91%-17.82M

-31.28%883K

-1,592.83%-13.94M

-496.45%-3.24M

-179.91%-1.52M

-47.01%4.94M

-53.19%1.29M

-59.41%934K

-69.96%817K

Other non cash items

17.69%153K

1,900.55%82.96M

--2.4M

1,843.79%80.43M

--0

124.14%130K

83,040.00%4.15M

--0

138,033.33%4.14M

---49K

Change In working capital

66.31%-8.65M

-371.86%-37.32M

-28.58%7.65M

-133.80%-3.61M

-1,687.66%-15.7M

-196.40%-25.67M

173.38%13.73M

93.55%10.72M

43.79%10.68M

212.00%989K

-Change in receivables

69.61%-6.98M

-1,027.62%-43.08M

-395.92%-5.47M

-2,201.20%-5.25M

-1,073.47%-9.39M

-483.85%-22.96M

-504.43%-3.82M

-18,466.67%-1.1M

175.08%250K

239.65%965K

-Change in inventory

-846.79%-4.31M

-544.98%-4.74M

-2,121.10%-6.61M

139.00%1.72M

-1,739.13%-423K

1,241.86%577K

133.08%1.07M

135.54%327K

388.44%718K

99.15%-23K

-Change in prepaid assets

-533.51%-1.21M

-617.72%-5.79M

203.26%1.43M

-1,056.55%-5.33M

-392.60%-1.7M

66.07%-191K

-120.29%-807K

-1,894.81%-1.38M

-82.66%557K

-3.49%581K

-Change in payables and accrued expense

231.07%3.94M

-5.56%16.62M

41.96%18.39M

-42.18%5.34M

-797.37%-4.1M

27.27%-3.01M

336.46%17.6M

100.74%12.95M

109.81%9.24M

-123.89%-457K

-Change in other current liabilities

-8.54%-89K

-10.10%-338K

-10.26%-86K

-8.86%-86K

-9.09%-84K

-12.33%-82K

-135.53%-307K

0.00%-78K

---79K

---77K

Cash from discontinued investing activities

Operating cash flow

164.50%31.93M

23.74%143.6M

38.85%55.65M

9.27%45.13M

17.42%30.75M

42.37%12.07M

92.22%116.05M

109.00%40.08M

90.27%41.3M

67.09%26.19M

Investing cash flow

Cash flow from continuing investing activities

99.88%-199K

-3,287.12%-293.5M

-38.32M

-70,215.91%-92.82M

-162.37M

183.56%9.21M

-94.12%-132K

333.47%9.34M

Net PPE purchase and sale

-168.92%-199K

-696.55%-231K

---93K

---64K

--0

---74K

97.16%-29K

--0

-2,800.00%-29K

Net intangibles purchase and sale

----

---81.51M

---2.23M

----

--0

----

Net investment purchase and sale

----

-169.99%-13.47M

--0

-236.45%-13.47M

----

292.38%19.24M

--0

--9.87M

----

Net other investing changes

----

-1,882.93%-198.29M

---36M

--0

---162.29M

---10M

--0

----

Cash from discontinued investing activities

Investing cash flow

99.88%-199K

-3,287.12%-293.5M

---38.32M

-70,215.91%-92.82M

--0

---162.37M

183.56%9.21M

--0

-94.12%-132K

333.47%9.34M

Financing cash flow

Cash flow from continuing financing activities

94,563.76%141.05M

-740.91%-10.86M

-129.52%-665K

-354.19%-10.13M

92.85%-214K

109.61%149K

120.80%1.69M

189.19%2.25M

289.90%3.98M

19.29%-2.99M

Net common stock issuance

--140.7M

--0

42.87%-6.91M

--0

-9.97%-4.36M

Proceeds from stock option exercised by employees

19.84%1.52M

-70.82%2.79M

-78.35%693K

-94.68%212K

-55.42%617K

27.00%1.27M

133.45%9.57M

367.30%3.2M

34.82%3.98M

410.70%1.38M

Net other financing activities

-5.00%-1.18M

-1,310.02%-13.65M

-43.25%-1.36M

---10.34M

---831K

---1.12M

-532.68%-968K

-597.06%-948K

--0

----

Cash from discontinued financing activities

Financing cash flow

94,563.76%141.05M

-740.91%-10.86M

-129.52%-665K

-354.19%-10.13M

92.85%-214K

109.61%149K

120.80%1.69M

189.19%2.25M

289.90%3.98M

19.29%-2.99M

Net cash flow

Beginning cash position

-53.87%137.64M

74.05%298.4M

-52.76%120.97M

-15.23%178.79M

-16.89%148.25M

74.05%298.4M

31.64%171.45M

65.38%256.07M

55.89%210.91M

40.09%178.37M

Current changes in cash

215.07%172.78M

-226.63%-160.76M

-60.63%16.67M

-228.04%-57.82M

-6.15%30.54M

-2,267.58%-150.15M

208.07%126.95M

154.86%42.33M

131.07%45.15M

308.43%32.54M

End cash Position

109.39%310.41M

-53.87%137.64M

-52.76%120.97M

-15.23%178.79M

-16.89%148.25M

74.05%298.4M

65.38%256.07M

55.89%210.91M

Free cash flow

164.47%31.73M

-46.68%61.86M

33.07%53.33M

-182.86%-34.22M

17.55%30.75M

41.50%12M

95.48%116.02M

109.44%40.08M

90.86%41.3M

66.91%26.16M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	164.50%31.93M	23.74%143.6M	38.85%55.65M	9.27%45.13M	17.42%30.75M	42.37%12.07M	92.22%116.05M	109.00%40.08M	90.27%41.3M	67.09%26.19M
Net income from continuing operations	-21.28%23.28M	-14.05%71.41M	36.80%34.84M	-235.24%-30.76M	74.67%37.76M	123.31%29.57M	110.42%83.08M	173.62%25.47M	120.23%22.75M	77.48%21.62M
Operating gains losses	6.25%68K	-74.03%262K	6.35%67K	-65.45%66K	--65K	--64K	245.55%1.01M	-17.11%63K	76.85%191K	----
Depreciation and amortization	42.88%9.43M	2,553.83%32.88M	1,386.67%9.14M	1,449.37%8.57M	23,062.16%8.57M	19,311.76%6.6M	545.31%1.24M	1,763.64%615K	1,683.87%553K	19.35%37K
Deferred tax	-14.94%-1.75M	-460.91%-17.82M	-31.28%883K	-1,592.83%-13.94M	-496.45%-3.24M	-179.91%-1.52M	-47.01%4.94M	-53.19%1.29M	-59.41%934K	-69.96%817K
Other non cash items	17.69%153K	1,900.55%82.96M	--2.4M	1,843.79%80.43M	--0	124.14%130K	83,040.00%4.15M	--0	138,033.33%4.14M	---49K
Change In working capital	66.31%-8.65M	-371.86%-37.32M	-28.58%7.65M	-133.80%-3.61M	-1,687.66%-15.7M	-196.40%-25.67M	173.38%13.73M	93.55%10.72M	43.79%10.68M	212.00%989K
-Change in receivables	69.61%-6.98M	-1,027.62%-43.08M	-395.92%-5.47M	-2,201.20%-5.25M	-1,073.47%-9.39M	-483.85%-22.96M	-504.43%-3.82M	-18,466.67%-1.1M	175.08%250K	239.65%965K
-Change in inventory	-846.79%-4.31M	-544.98%-4.74M	-2,121.10%-6.61M	139.00%1.72M	-1,739.13%-423K	1,241.86%577K	133.08%1.07M	135.54%327K	388.44%718K	99.15%-23K
-Change in prepaid assets	-533.51%-1.21M	-617.72%-5.79M	203.26%1.43M	-1,056.55%-5.33M	-392.60%-1.7M	66.07%-191K	-120.29%-807K	-1,894.81%-1.38M	-82.66%557K	-3.49%581K
-Change in payables and accrued expense	231.07%3.94M	-5.56%16.62M	41.96%18.39M	-42.18%5.34M	-797.37%-4.1M	27.27%-3.01M	336.46%17.6M	100.74%12.95M	109.81%9.24M	-123.89%-457K
-Change in other current liabilities	-8.54%-89K	-10.10%-338K	-10.26%-86K	-8.86%-86K	-9.09%-84K	-12.33%-82K	-135.53%-307K	0.00%-78K	---79K	---77K
Cash from discontinued investing activities
Operating cash flow	164.50%31.93M	23.74%143.6M	38.85%55.65M	9.27%45.13M	17.42%30.75M	42.37%12.07M	92.22%116.05M	109.00%40.08M	90.27%41.3M	67.09%26.19M
Investing cash flow
Cash flow from continuing investing activities	99.88%-199K	-3,287.12%-293.5M	-38.32M	-70,215.91%-92.82M	0	-162.37M	183.56%9.21M	0	-94.12%-132K	333.47%9.34M
Net PPE purchase and sale	-168.92%-199K	-696.55%-231K	---93K	---64K	--0	---74K	97.16%-29K	--0	--0	-2,800.00%-29K
Net intangibles purchase and sale	----	---81.51M	---2.23M	----	----	----	--0	--0	----	----
Net investment purchase and sale	----	-169.99%-13.47M	--0	-236.45%-13.47M	----	----	292.38%19.24M	--0	--9.87M	----
Net other investing changes	----	-1,882.93%-198.29M	---36M	--0	--0	---162.29M	---10M	--0	----	----
Cash from discontinued investing activities
Investing cash flow	99.88%-199K	-3,287.12%-293.5M	---38.32M	-70,215.91%-92.82M	--0	---162.37M	183.56%9.21M	--0	-94.12%-132K	333.47%9.34M
Financing cash flow
Cash flow from continuing financing activities	94,563.76%141.05M	-740.91%-10.86M	-129.52%-665K	-354.19%-10.13M	92.85%-214K	109.61%149K	120.80%1.69M	189.19%2.25M	289.90%3.98M	19.29%-2.99M
Net common stock issuance	--140.7M	--0	--0	--0	--0	--0	42.87%-6.91M	--0	--0	-9.97%-4.36M
Proceeds from stock option exercised by employees	19.84%1.52M	-70.82%2.79M	-78.35%693K	-94.68%212K	-55.42%617K	27.00%1.27M	133.45%9.57M	367.30%3.2M	34.82%3.98M	410.70%1.38M
Net other financing activities	-5.00%-1.18M	-1,310.02%-13.65M	-43.25%-1.36M	---10.34M	---831K	---1.12M	-532.68%-968K	-597.06%-948K	--0	----
Cash from discontinued financing activities
Financing cash flow	94,563.76%141.05M	-740.91%-10.86M	-129.52%-665K	-354.19%-10.13M	92.85%-214K	109.61%149K	120.80%1.69M	189.19%2.25M	289.90%3.98M	19.29%-2.99M
Net cash flow
Beginning cash position	-53.87%137.64M	74.05%298.4M	-52.76%120.97M	-15.23%178.79M	-16.89%148.25M	74.05%298.4M	31.64%171.45M	65.38%256.07M	55.89%210.91M	40.09%178.37M
Current changes in cash	215.07%172.78M	-226.63%-160.76M	-60.63%16.67M	-228.04%-57.82M	-6.15%30.54M	-2,267.58%-150.15M	208.07%126.95M	154.86%42.33M	131.07%45.15M	308.43%32.54M
End cash Position	109.39%310.41M	-53.87%137.64M	-53.87%137.64M	-52.76%120.97M	-15.23%178.79M	-16.89%148.25M	74.05%298.4M	74.05%298.4M	65.38%256.07M	55.89%210.91M
Free cash flow	164.47%31.73M	-46.68%61.86M	33.07%53.33M	-182.86%-34.22M	17.55%30.75M	41.50%12M	95.48%116.02M	109.44%40.08M	90.86%41.3M	66.91%26.16M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall